Exploring patient-reported barriers to participating in proton therapy clinical trials-Reference-Cited by-同舟云学术

Exploring patient-reported barriers to participating in proton therapy clinical trials

Published:2024-03 Issue: Volume:29 Page:100230
ISSN:2405-6324
Container-title:Technical Innovations & Patient Support in Radiation Oncology
language:en
Short-container-title:Technical Innovations & Patient Support in Radiation Oncology

Author:

Wilhøft Kristensen Anne,Lunde Jensen Annesofie,Jensen Kenneth,Oksbjerre Dalton Susanne,Friborg Jeppe,Grau Cai^ORCID

Publisher

Elsevier BV

Subject

Care Planning,Health Policy,Oncology (nursing),Radiology, Nuclear Medicine and imaging

Reference42 articles.

1. Head and Neck Cancer;Chow;N Engl J Med,2020

2. Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes;Sio;Int J Radiat Oncol Biol Phys,2016

3. Considerations for study design in the DAHANCA 35 trial of protons versus photons for head and neck cancer The impact of late treatment-toxicity on generic health-related quality of life in head and neck cancer patients after radiotherapy;Friborg;Radiother Oncol,2023

4. The impact of late treatment-toxicity on generic health-related quality of life in head and neck cancer patients after radiotherapy;Ramaekers;Oral Oncol,2011

5. Proton therapy and the European Particle Therapy Network: The past, present and future;Weber;CancerRadiother,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute toxicities in proton therapy for head and neck cancer – A matched analysis of the DAHANCA 35 feasibility study;Clinical and Translational Radiation Oncology;2024-09

2. Physician barriers and dilemmas in the execution of clinical trials impacting decision-making in the DAHANCA 35 proton therapy trial for head and neck cancer;Technical Innovations & Patient Support in Radiation Oncology;2024-09